deCode Genetics ehf
50Patents
26Active
50Granted
44Portfolio score
Filing activity: Oct 25, 1999 → Mar 26, 2012 · 25 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7146375B2 | Inference control method in a data cube | Emerging Cross-Sectional Technologies | 86 | Expired |
| US7016910B2 | Indexing, rewriting and efficient querying of relations referencing semistructured data | Emerging Cross-Sectional Technologies | 45 | Expired |
| US7152073B2 | Method and system for defining sets by querying relational data using a set definition language | Emerging Cross-Sectional Technologies | 37 | Expired |
| US6434557B1 | Online syntheses programming technique | Emerging Cross-Sectional Technologies | 36 | Expired |
| US6418427B1 | Online modifications of dimension structures in multidimensional processing | Emerging Cross-Sectional Technologies | 36 | Expired |
| US7115586B2 | Non-inclusion cyclodextrin complexes | Human Necessities | 32 | Expired |
| US6578028B2 | SQL query generator utilizing matrix structures | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6970874B2 | Populating data cubes using calculated relations | Emerging Cross-Sectional Technologies | 27 | Expired |
| US6356900B1 | Online modifications of relations in multidimensional processing | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6225093A | Detection of C4A deletion by long range PCR | Chemistry; Metallurgy | 20 | Expired |
| US7402684B2 | Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation | Chemistry; Metallurgy | 10 | Active |
| US7674802B2 | N-linked aryl heteroaryl inhibitors of LTA4H for treating inflammation | Chemistry; Metallurgy | 9 | Active |
| US7404079B2 | Automatic identity protection system with remote third party monitoring | Electricity | 9 | Expired |
| US7750012B2 | Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammation | Chemistry; Metallurgy | 8 | Active |
| US7384736B2 | Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease | Physics | 6 | Expired |
| US6897027B2 | Method for desalting nucleic acids | Chemistry; Metallurgy | 5 | Expired |
| US6630304B1 | Human osteoporosis gene | Chemistry; Metallurgy | 5 | Expired |
| US8796182B2 | Genetic markers associated with risk of diabetes mellitus | Chemistry; Metallurgy | 4 | Active |
| US8367333B2 | Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction | Emerging Cross-Sectional Technologies | 4 | Active |
| US8828657B2 | Susceptibility variants for lung cancer | Chemistry; Metallurgy | 4 | Active |
| US7244571B2 | Methods for producing Ex vivo models for inflammatory disease and uses thereof | Physics | 3 | Expired |
| US8791267B2 | Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders | Chemistry; Metallurgy | 3 | Active |
| US8795963B2 | Genetic markers for risk management of atrial fibrillation and stroke | Chemistry; Metallurgy | 3 | Active |
| US8951735B2 | Genetic variants for breast cancer risk assessment | Emerging Cross-Sectional Technologies | 3 | Active |
| US7598397B2 | Sulfonamide peri-substituted bicyclics for occlusive artery disease | Chemistry; Metallurgy | 2 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.